Diabetes, Vol 38, Issue 4 491-498, Copyright © 1989 by American Diabetes Association

ARTICLES

Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group

In a double-blind randomized controlled clinical trial conducted in two French and two United Kingdom centers, the effect of antiplatelet agents, i.e., aspirin alone (330 mg 3 times daily) or in combination with dipyridamole (75 mg 3 times daily), was tested versus placebo in 475 patients with early diabetic retinopathy. The assessment of retinopathy was based on change in the number of microaneurysms (MAs) present in the macular field, as seen on fluorescein angiograms, over 3 yr. Forty-one patients did not complete the study. At least three readable initial and yearly angiograms were available on 420 patients (266 treated with insulin and 154 not treated); the results reported are based on these patients. The mean yearly increase in definite MAs was similar in insulin-treated and non-insulin-treated diabetic patients. There was no significant difference between the aspirin-alone group (0.69 +/- 5.1 mean +/- SD, n = 145) and the aspirin-plus-dipyridamole group (0.34 +/- 3.0, n = 142). In the placebo group the mean yearly increase (1.44 +/- 4.5, n = 133) was significantly higher than in the treated group (P = .02, 1-tailed t test). There was a clear relationship between the deterioration in ophthalmological signs and the increase in mean yearly MAs (clinically stable, 0.38 +/- 3.96, n = 293; deteriorating, 1.79 +/- 4.89, n = 127; P = .002, 2-tailed t test). We conclude that aspirin alone and in conjunction with dipyridamole significantly slows the progression of MA evolution in early diabetic retinopathy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Q. Mohamed, M. C. Gillies, and T. Y. Wong Management of Diabetic Retinopathy: A Systematic Review JAMA, August 22, 2007; 298(8): 902 - 916. [Abstract] [Full Text] [PDF]

				L. Zheng, S. J. Howell, D. A. Hatala, K. Huang, and T. S. Kern Salicylate-Based Anti-Inflammatory Drugs Inhibit the Early Lesion of Diabetic Retinopathy Diabetes, February 1, 2007; 56(2): 337 - 345. [Abstract] [Full Text] [PDF]

				T. S. Kern, C. M. Miller, Y. Du, L. Zheng, S. Mohr, S. L. Ball, M. Kim, J. A. Jamison, and D. P. Bingaman Topical Administration of Nepafenac Inhibits Diabetes-Induced Retinal Microvascular Disease and Underlying Abnormalities of Retinal Metabolism and Physiology Diabetes, February 1, 2007; 56(2): 373 - 379. [Abstract] [Full Text] [PDF]

				W. Sun, C. Gerhardinger, Z. Dagher, T. Hoehn, and M. Lorenzi Aspirin at Low-Intermediate Concentrations Protects Retinal Vessels in Experimental Diabetic Retinopathy Through Non-Platelet-Mediated Effects Diabetes, December 1, 2005; 54(12): 3418 - 3426. [Abstract] [Full Text] [PDF]

				K. A. Goatman, M. J. Cree, J. A. Olson, J. V. Forrester, and P. F. Sharp Automated Measurement of Microaneurysm Turnover Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5335 - 5341. [Abstract] [Full Text] [PDF]

				E. M Kohner Aspirin for diabetic retinopathy BMJ, November 8, 2003; 327(7423): 1060 - 1061. [Full Text] [PDF]

				E.L.L.M. De Schryver Dipyridamole in Stroke Prevention: Effect of Dipyridamole on Blood Pressure Stroke, October 1, 2003; 34(10): 2339 - 2342. [Abstract] [Full Text] [PDF]

				T. A. Ciulla, A. G. Amador, and B. Zinman Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies Diabetes Care, September 1, 2003; 26(9): 2653 - 2664. [Abstract] [Full Text] [PDF]

				E.L.L.M. De Schryver, A. Algra, and J. van Gijn Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular Disease Stroke, August 1, 2003; 34(8): 2072 - 2080. [Abstract] [Full Text] [PDF]

				E. M Kohner Review: Thirty-seven years with diabetic retinopathy The British Journal of Diabetes & Vascular Disease, November 1, 2002; 2(6): 452 - 456. [Abstract] [PDF]

				S. E. Straus, S. R. Majumdar, and F. A. McAlister New Evidence for Stroke Prevention: Scientific Review JAMA, September 18, 2002; 288(11): 1388 - 1395. [Abstract] [Full Text] [PDF]

				C. Kluft and J. Jespersen Review: Diabetes as a procoagulant condition The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 358 - 362. [Abstract] [PDF]

				T. S. Kern and R. L. Engerman Pharmacological Inhibition of Diabetic Retinopathy: Aminoguanidine and Aspirin Diabetes, July 1, 2001; 50(7): 1636 - 1642. [Abstract] [Full Text] [PDF]

				D. Boeri, M. Maiello, and M. Lorenzi Increased Prevalence of Microthromboses in Retinal Capillaries of Diabetic Individuals Diabetes, June 1, 2001; 50(6): 1432 - 1439. [Abstract] [Full Text]

				R. Klein, B. E. K. Klein, and S. E. Moss How Many Steps of Progression of Diabetic Retinopathy Are Meaningful?: The Wisconsin Epidemiologic Study of Diabetic Retinopathy Arch Ophthalmol, April 1, 2001; 119(4): 547 - 553. [Abstract] [Full Text] [PDF]

				R. H. Mehta, T. J. Ruane, P. A. McCargar, K. A. Eagle, and E. J. Stalhandske The Treatment of Elderly Diabetic Patients With Acute Myocardial Infarction: Insight From Michigan's Cooperative Cardiovascular Project Arch Intern Med, May 8, 2000; 160(9): 1301 - 1306. [Abstract] [Full Text] [PDF]

				J. L. Wilterdink and J. D. Easton Dipyridamole Plus Aspirin in Cerebrovascular Disease Arch Neurol, September 1, 1999; 56(9): 1087 - 1092. [Abstract] [Full Text] [PDF]

				M. Eccles, N. Freemantle, J. Mason, and t. N. o. E. A. G. D. Group North of England evidence based guideline development project: guideline on the use of aspirin as secondary prophylaxis for vascular disease in primary care BMJ, April 25, 1998; 316(7140): 1303 - 1309. [Full Text]

				J. P. De La Cruz, A. Moreno, M. Muñoz, J. M. G. Campos, and F. S. De La Cuesta Effect of Aspirin Plus Dipyridamole on the Retinal Vascular Pattern in Experimental Diabetes Mellitus J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 454 - 459. [Abstract] [Full Text]

				C. M. Clark and D. A. Lee Prevention and Treatment of the Complications of Diabetes Mellitus N. Engl. J. Med., May 4, 1995; 332(18): 1210 - 1217. [Full Text] [PDF]

				Antiplatelet Trialists Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients BMJ, January 8, 1994; 308(6921): 81 - 106. [Abstract] [Full Text]

				D. M. Nathan Long-Term Complications of Diabetes Mellitus N. Engl. J. Med., June 10, 1993; 328(23): 1676 - 1685. [Full Text]